Stereotaxis Inc (STXS):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Stereotaxis Inc (STXS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7025
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stereotaxis Inc (Stereotaxis) designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch solution is an advanced remote robotic navigation system for use in interventional lab for the treatment of arrhythmias and coronary artery disease. The Epoch solution consists of Niobe ES robotic magnetic navigation system, Odyssey information management solution and Vdrive robotic navigation system. It also offers maintenance and support services for its integrated products. The company markets its products and services through direct sales force and through strategic alliances with other companies in the US, Europe and other parts of the world. Stereotaxis is headquartered in St. Louis, Missouri, the US.

Stereotaxis Inc (STXS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stereotaxis Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stereotaxis Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stereotaxis Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stereotaxis Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Stereotaxis Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Stereotaxis Inc, Medical Equipment, Deal Details 10
Partnerships 10
Stereotaxis and Acutus Medical Enter into Agreement 10
Equity Offering 11
Stereotaxis Raises USD24 Million in Private Placement of Series A Preferred Stock and Warrants 11
Stereotaxis Announces Public Offering of Shares for Up To USD18 Million 13
Stereotaxis Completes Rights Offering Of Shares For US$10.2 Million 14
Stereotaxis Files Registration Statement For Public Offering Of Securities For Up To US$75 Million 15
Stereotaxis Completes Private Placement Of Shares For US$10 Million 16
Stereotaxis Inc – Key Competitors 17
Stereotaxis Inc – Key Employees 18
Stereotaxis Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Aug 07, 2018: Stereotaxis reports 2018 second quarter financial results 20
Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results 22
Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results 24
Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results 25
Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 27
May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results 28
Corporate Communications 29
Jun 04, 2018: Stereotaxis Announces Changes to its Board of Directors 29
Feb 06, 2017: Stereotaxis Announces Management Transition and 2016 Financial Results 30
Product News 32
May 01, 2018: Stereotaxis Announces Publication of Clinical Research Supplement Highlighting Robotic Navigation for Cardiac Arrhythmias 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Stereotaxis Inc, Medical Equipment, Key Facts, 2017 2
Stereotaxis Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Stereotaxis Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stereotaxis Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stereotaxis Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stereotaxis Inc, Deals By Market, 2012 to YTD 2018 8
Stereotaxis Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Stereotaxis and Acutus Medical Enter into Agreement 10
Stereotaxis Raises USD24 Million in Private Placement of Series A Preferred Stock and Warrants 11
Stereotaxis Announces Public Offering of Shares for Up To USD18 Million 13
Stereotaxis Completes Rights Offering Of Shares For US$10.2 Million 14
Stereotaxis Files Registration Statement For Public Offering Of Securities For Up To US$75 Million 15
Stereotaxis Completes Private Placement Of Shares For US$10 Million 16
Stereotaxis Inc, Key Competitors 17
Stereotaxis Inc, Key Employees 18
Stereotaxis Inc, Other Locations 19
Stereotaxis Inc, Subsidiaries 19

List of Figures
Stereotaxis Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Stereotaxis Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Stereotaxis Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Stereotaxis Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stereotaxis Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Stereotaxis Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stereotaxis Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Stereotaxis Inc (STXS):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bioxyne Ltd (BXN):企業の財務・戦略的SWOT分析
    Bioxyne Ltd (BXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Faron Pharmaceuticals Oy (FARN)-製薬・医療分野:企業M&A・提携分析
    Summary Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the tr …
  • Sembcorp Industries Ltd:企業の戦略・SWOT・財務情報
    Sembcorp Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Sembcorp Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Logan Resources Ltd:企業の戦略・SWOT・財務情報
    Logan Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Logan Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • GenomeDx Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary GenomeDx Biosciences Inc (GenomeDx) is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. The company offers decipher prostate cancer classifier, a transformative genomic test that provides an assessment of tumor agg …
  • Mustang Survival Corp.:企業の戦略・SWOT・財務情報
    Mustang Survival Corp. - Strategy, SWOT and Corporate Finance Report Summary Mustang Survival Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Industrias Penoles SAB de CV:企業の戦略・SWOT・財務情報
    Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Diagnostic & Therapeutic Center of Athens Hygeia SA (HYGEIA):企業の財務・戦略的SWOT分析
    Diagnostic & Therapeutic Center of Athens Hygeia SA (HYGEIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the com …
  • HeartSciences:医療機器:M&Aディール及び事業提携情報
    Summary HeartSciences, formerly Heart Test Laboratories Inc, is a medical device company that offers cardiac care products. The company develops, manufactures and markets cardiac testing tools for the early detection of heart disease. It offers MyoVista, a screening tool used to determine the presen …
  • Aptus Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Aptus Health Inc (Aptus), formerly Physicians Interactive Inc, a subsidiary of Merck & Co Inc, is a technology company that provides healthcare digital marketing solutions. The company offers strategy, solution design, customer segmentation, advertising, actionable analytic, commercial, paym …
  • Apex Biotechnology Corp (1733):医療機器:M&Aディール及び事業提携情報
    Summary Apex Biotechnology Corp (ApexBio) is a medical device company that develops, manufactures and commercializes biosensor-based blood glucose monitoring systems. The company provides patient self-testing products, point of care diagnostics and multi-functional products. It also imports and expo …
  • Plenus Company Limited
    Plenus Company Limited - Strategy, SWOT and Corporate Finance Report Summary Plenus Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nanomix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nanomix Inc (Nanomix) is a medical device company that develops analytical detection devices for the point of care diagnostics. The company provides Nanomix system, which is an automated system consisting of a handheld reader and self-contained assay cartridge with a carbon nanotube biosenso …
  • McWane, Inc.:企業の戦略・SWOT・財務分析
    McWane, Inc. - Strategy, SWOT and Corporate Finance Report Summary McWane, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Detour Gold Corp
    Detour Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Detour Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • University of Southampton-製薬・医療分野:企業M&A・提携分析
    Summary University of Southampton (UOS) is an educational institute that offers undergraduate and postgraduate programs. The university offers educational programs across various disciplines including accounting and finance, acoustical engineering, aeronautics and astronautics, anthropology, archaeo …
  • EBOS Group Ltd (EBO):製薬・医療:M&Aディール及び事業提携情報
    Summary EBOS Group Ltd (EBOS) is a healthcare products supplier that markets, sells and distributes healthcare, medical and pharmaceutical products. It also markets and distributes animal care products and offers distribution, warehousing and logistics support to pharmaceutical manufacturers and med …
  • Columbus Energy Resources PLC (CERP):石油・ガス:M&Aディール及び事業提携情報
    Summary Columbus Energy Resources PLC (Columbus Energy), formerly LGO Energy Plc is an oil and gas exploration and development company. The company acquires, explores, develops and produces oil and gas properties. It operates oil and gas assets in Trinidad including the South West Peninsula licenses …
  • The Second Cup Ltd.:戦略・SWOT・企業財務分析
    The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • United States Lime & Minerals Inc:企業の戦略・SWOT・財務分析
    United States Lime & Minerals Inc - Strategy, SWOT and Corporate Finance Report Summary United States Lime & Minerals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆